Gateley Acquires Groom Wilkes & Wright in £9M Deal to Strengthen IP Services

Key numbers at a glance

Maximum consideration	Up to £9.0 million
Initial consideration	£5.725 million (subject to adjustments)
Consideration mix	75% cash / 25% shares
Issue price for consideration shares	£1.24 per share
GWW revenue (y/e 5 Apr 2025)	£4.7 million
GWW corporatised PBT	£1.4 million
GWW net assets	£0.3 million
Funding source	£80m revolving credit facility

What the price implies: quick-and-clean valuation take

On the disclosed figures, the initial payment of £5.725 million implies roughly 1.22x GWW’s last-year revenue (£5.725m / £4.7m) and about 4.1x corporatised PBT (£5.725m / £1.4m). On the maximum consideration of £9.0 million, those rough multiples step up to around 1.91x revenue and 6.4x corporatised PBT.

Two caveats. First, the earn-out is based on EBITDA, but EBITDA is not disclosed, so treat any EBITDA-related inference with care. Second, PBT here is “corporatised” and may not be directly comparable to Gateley’s group metrics. Still, on face value this looks like a sensibly priced, earnings-accretive bolt-on if performance holds.

Share issuance and possible dilution

Gateley will settle 25% of consideration in shares at £1.24 per share. The exact share count will be confirmed once completion accounts are finalised and on any future earn-out tranches. For context only:

• If the initial consideration remained at £5.725 million, the equity element would be approximately £1.43 million – about 1.15 million new shares at £1.24.
• On the full £9.0 million maximum, the 25% equity portion would be £2.25 million – roughly 1.81 million shares at £1.24.

These figures are indicative; the actual number of shares will be determined and announced separately on Admission.

Strategic fit: building a scaled IP and brands platform

Gateley’s stated strategy is to build a trade mark attorney and patent services offering through organic growth and acquisitions, adding specialisms and coverage. GWW plugs straight into that, deepening trade mark capabilities and broadening the client roster.

With Adamson Jones and Symbiosis IP already in the stable, the group is stitching together a more complete IP service spanning legal advice, trade mark and patent attorney work, and sector expertise (including life sciences via Symbiosis IP). That integrated model often supports cross-selling and stickier client relationships.

What I like and what to watch

Positives

• Strategic clarity: this is a straight-line continuation of Gateley’s IP build-out, not a random detour.
• Credible financials: GWW posts £4.7 million revenue and £1.4 million corporatised PBT, suggesting a healthy margin profile for a specialist boutique.
• Aligned incentives: two-year EBITDA-based earn-out and full management retention support continuity.
• Balanced consideration: mix of cash and shares limits immediate cash drain while sharing upside with sellers.

Watch-outs

• Integration execution: marrying processes and culture across multiple IP acquisitions needs careful handling.
• Earn-out sensitivity: the ultimate price depends on EBITDA delivery over two years; underperformance reduces the cost but also the strategic benefit.
• Disclosure gaps: EBITDA is not disclosed, and the timing/size of Admission for new shares is “to be announced”.
• Financing environment: the initial cash draw comes from the £80m revolving credit facility; overall leverage metrics are not disclosed.

What to track next from Gateley

• Admission RNS for the initial consideration shares, confirming the number of shares issued.
• Early evidence of cross-selling between GWW, Adamson Jones and Symbiosis IP.
• Run-rate performance of the combined IP offering and any updates on the earn-out trajectory.
• Further acquisitions within the IP and brands vertical, consistent with the platform strategy.

My take: a sensibly priced, strategic bolt-on

This looks like a tidy, on-message deal that bolsters Gateley’s IP credentials at a price that, on disclosed figures, appears reasonable. The earn-out ties cost to performance, management is staying put, and the service line fit is clear. The absence of EBITDA disclosure limits precision, but the broad economics suggest the acquisition could be earnings-enhancing if GWW maintains momentum.

Overall, I’d mark this as a positive step in Gateley’s plan to build a scaled, defensible IP and brands platform. Execution will do the talking from here.